Evidence map›Paper›PMID 33824316›Full record

ArticleNature communications2021

Thiazoline-related innate fear stimuli orchestrate hypothermia and anti-hypoxia via sensory TRPA1 activation.

Tomohiko Matsuo, Tomoko Isosaka, Yuichiro Hayashi, Lijun Tang, Akihiro Doi, Aiko Yasuda, Mikio Hayashi, Chia-Ying Lee, Liqin Cao, Natsumaro Kutsuna and 10 more

Abstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. A neuro-behavioural model of neophobia.Biological reviews of the Cambridge Philosophical Society · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Tomohiko MatsuoDepartment of Functional Neuroscience, Institute of Biomedical Science, Kansai Medical University, Osaka, Japan.
Tomoko IsosakaDepartment of Functional Neuroscience, Institute of Biomedical Science, Kansai Medical University, Osaka, Japan.
Yuichiro HayashiDepartment of Functional Neuroscience, Institute of Biomedical Science, Kansai Medical University, Osaka, Japan.
Lijun TangDepartment of Functional Neuroscience, Institute of Biomedical Science, Kansai Medical University, Osaka, Japan.
Akihiro DoiDepartment of Functional Neuroscience, Institute of Biomedical Science, Kansai Medical University, Osaka, Japan.ORCID 0000-0002-7809-6570
Aiko YasudaDepartment of Functional Neuroscience, Institute of Biomedical Science, Kansai Medical University, Osaka, Japan.
Mikio HayashiDepartment of Cellular and Functional Biology, Institute of Biomedical Science, Kansai Medical University, Osaka, Japan.ORCID 0000-0002-9670-5683
Chia-Ying LeeInternational Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Ibaraki, Japan.
Liqin CaoInternational Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Ibaraki, Japan.
Natsumaro KutsunaDepartment of Integrated Biosciences, Graduate School of Frontier Sciences, University of Tokyo, Chiba, Japan.
Sachihiro MatsunagaDepartment of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, Chiba, Japan.ORCID 0000-0003-3024-3559
Takeshi MatsudaDepartment of Optical Imaging, Institute for Medical Photonics Research, PMPERC and IMIC, Hamamatsu University School of Medicine, Shizuoka, Japan.
Ikuko YaoDepartment of Optical Imaging, Institute for Medical Photonics Research, PMPERC and IMIC, Hamamatsu University School of Medicine, Shizuoka, Japan.
Mitsuyoshi SetouDepartment of Cellular and Molecular Anatomy and IMIC, Hamamatsu University School of Medicine, Shizuoka, Japan.
Dai KanagawaDepartment of Functional Neuroscience, Institute of Biomedical Science, Kansai Medical University, Osaka, Japan.
Koichiro HigasaDepartment of Genome Analysis, Institute of Biomedical Science, Kansai Medical University, Osaka, Japan.
Masahito IkawaResearch Institute for Microbial Diseases, Osaka University, Osaka, Japan.ORCID 0000-0001-9859-6217
Qinghua LiuInternational Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba, Tsukuba, Ibaraki, Japan. linqinghua@nibs.ac.cn.ORCID 0000-0002-5996-0634
Reiko KobayakawaDepartment of Functional Neuroscience, Institute of Biomedical Science, Kansai Medical University, Osaka, Japan. kobayakr@hirakata.kmu.ac.jp.ORCID 0000-0001-6613-5969
Ko KobayakawaDepartment of Functional Neuroscience, Institute of Biomedical Science, Kansai Medical University, Osaka, Japan. kobayakk@hirakata.kmu.ac.jp.ORCID 0000-0001-6406-5610

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thiazoline-related innate fear-eliciting compounds (tFOs) orchestrate hypothermia, hypometabolism, and anti-hypoxia, which enable survival in lethal hypoxic conditions. Here, we show that most of these effects are severely attenuated in transient receptor potential ankyrin 1 (Trpa1) knockout mice. TFO-induced hypothermia involves the Trpa1-mediated trigeminal/vagal pathways and non-Trpa1 olfactory pathway. TFOs activate Trpa1-positive sensory pathways projecting from trigeminal and vagal ganglia to the spinal trigeminal nucleus (Sp5) and nucleus of the solitary tract (NTS), and their artificial activation induces hypothermia. TFO presentation activates the NTS-Parabrachial nucleus pathway to induce hypothermia and hypometabolism; this activation was suppressed in Trpa1 knockout mice. TRPA1 activation is insufficient to trigger tFO-mediated anti-hypoxic effects; Sp5/NTS activation is also necessary. Accordingly, we find a novel molecule that enables mice to survive in a lethal hypoxic condition ten times longer than known tFOs. Combinations of appropriate tFOs and TRPA1 command intrinsic physiological responses relevant to survival fate.

Indexed as

AnimalsBradycardiaFearGene Expression RegulationHEK293 CellsHumansHypothermiaHypoxiaMaleMiceMice, Inbred C57BLNeuronsOxygen ConsumptionSensationThiazolesTime FactorsThiazolesTRPA1 Cation ChannelTrpa1 protein, mouse

Identifiers

PMID33824316
PMCPMC8024280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.